Organization · Venture Capital
Westlake BioPartners®
Westlake BioPartners is a life science venture capital firm based in Westlake Village, California, focused on early-stage biopharma investments. The firm emphasizes a people-first approach, providing hands-on support to entrepreneurs throughout the development process.
Overview
What Westlake BioPartners® does
What Westlake BioPartners® is
Westlake BioPartners is a life science venture capital firm based in Westlake Village, California, focused on early-stage biopharma investments. The firm emphasizes a people-first approach, providing hands-on support to entrepreneurs throughout the development process.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2018
- Approximate age
- About 8 years
- Structured capabilities
- Funder
- Last reviewed
- April 29, 2026
Official channels
Find Westlake BioPartners® elsewhere
Open the official website or a supported primary organization account.
Capability profile
Westlake BioPartners® as a funder
Investment thesis
Westlake BioPartners builds companies around world-class entrepreneurs, providing hands-on support, community connections, and capital to develop transformative therapies in life sciences.
Focus narrative
Westlake BioPartners invests in life sciences, specifically targeting the development of new medicines. The firm emphasizes a people-first approach, working closely with entrepreneurs to guide them through various stages of company formation and growth. Their concentrated portfolio allows for personal attention and access to innovation, capital, and community.
Value beyond capital
Westlake BioPartners provides hands-on support, community connections, and capital to its portfolio companies. The firm focuses on matching promising technologies with world-class talent, guiding companies through ideation, preclinical research, and clinical development.
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B · Growth Equity
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 7
Portfolio context
AllRock Bio: A clinical-stage company developing a small molecule pan-ROCK inhibitor for pulmonary and fibrotic indications. 3T Biosciences: An immunotherapy company focused on next-generation therapies for broad patient populations. Arsenal: A clinical-stage programmable cell therapy company targeting solid tumor therapies. Borealis Biosciences: A company advancing RNA medicines for precision targeting of kidney diseases. Capsida: Focused on engineering novel AAVs and developing gene therapies. Electra: Developing therapies targeting signal regulatory proteins for immunological diseases and cancer. Kyverna: A clinical-stage biopharmaceutical company developing cell therapies for autoimmune diseases.
Common questions
What to know about Westlake BioPartners®
Upseed classifies Westlake BioPartners® under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 29, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.